Avaliação da maturidade em Indústria 4.0 em uma empresa farmacêutica brasileira: aplicação do modelo PIMM 4.0

Abstract

This study aims to evaluate the maturity of Industry 4.0 in a pharmaceutical company located in São Paulo, identifying technological, strategic, and cultural advances and challenges through the PIMM 4.0 model. The concepts of Industry 4.0, international maturity models (IMPULS, Acatech, PwC, ISO), and the PIMM 4.0 model, developed for the Brazilian context, were addressed. The relevance of the pharmaceutical sector stands out, characterized by high regulation, intense R&D activity, and demand for traceability, factors that impact the implementation of Industry 4.0 technologies. This is a quantitative and descriptive case study applied to a pharmaceutical company, whose data collection was carried out using the structured questionnaire of PIMM 4.0, evaluating eight dimensions: Products and Services, Manufacturing and Operations, Strategy and Organization, Supply Chain, Business Model, Interoperability, People and Culture, and Sustainability. Each dimension was measured on a Likert scale from 1 to 4, and the data analyzed using averages and radar charts. The results indicate that the company presents intermediate maturity, with levels 2 (Technological) and 3 (Transition) predominating. Dimensions such as Products and Services, Supply Chain, Business Model, Inter operability, and Sustainability are in a transition stage, while Manufacturing and Operations, Strategy and Organization, and People and Culture reveal significant weaknesses. Despite technological investments, organizational and cultural gaps still limit the full adoption of Industry 4.0. Assessment through PIMM 4.0 provides a precise diagnosis of the maturity level, allowing the company to identify critical areas and direct efforts towards training, technological integration, and cultural change, aligning strategy and technology to advance digital transformation. The research highlights the challenges and opportunities of the Brazilian pharmaceutical sector in the Industry 4.0 era, demonstrating the applicability of PIMM 4.0 as a tool adapted to the national context and emphasizing the importance of policies and practices for technological integration and human development.